InvestorInvestor relations

Hualan Bio Will Attend CPHI Shanghai in June 18-20, 2019

Hualan Bio Will Attend CPHI Shanghai in June 18-20, 2019

CPHI will be held in Shanghai New International Expo Center (Pudong SNIEC) from June 18 - 20, 2019. Hualan Bio will attend as scheduled. Booth number is W4G66.

Founded in 1992, Hualan Bio is a national high-tech enterprise which engages in the production, R&D and marketing of plasma products, vaccines, and antibodies, one of the largest manufacturing enterprises of plasma products and vaccines in China. Hualan Bio owns 25 plasma collection stations in China, with steady and enough plasma supply. Hualan Bio’s property is throughout Henan, Chongqing, Beijing and other 6 provinces and cities, and owns 30 subsidiaries. The influenza vaccine had passed GMP of Ukraine, Cote d'Ivoire, WHO-PQ. The plasma products and vaccines had been exported to countries in Asia, Europe, Africa and South America.

Shengming Bio is wholly owned subsidiary of Hualan Group and can provide CRO and CMO services related to monoclonal antibody drugs that fully meet the requirements of CFDA/FDA. The contents of services include screening monoclonal antibody, inspection and testing, evaluation, process R&D, drug analysis, preparation development, production approval application, filling and packaging, labeling, etc.

Hualan | Hualan Biological


TAG:  Hualan Bio, CPHI Shanghai, Shengming Bio, Plasma product, Vaccine product, Monoclonal Antibody